scholarly journals Is HbA1c the only choice? Alternative biomarkers for glycaemic control assessment

2017 ◽  
Vol 6 (4) ◽  
pp. 136-141 ◽  
Author(s):  
Edyta Cichocka ◽  
Janusz Gumprecht
Keyword(s):  
Glycaemic Control ◽  
Choice Alternative

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/mL in people with type 1 diabetes (EDITION 4)

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Ziemen ◽  
RM Bergenstal ◽  
MC Riddle ◽  
M Rojeski ◽  
M Espinasse ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Insulin Glargine

New insulin glargine 300 U/mL: glycaemic control and hypoclycaemia in insulin-naïve people with type 2 diabetes mellitus (EDITION 3)

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Ziemen ◽  
MC Riddle ◽  
RM Bergenstal ◽  
K Sestakauskas ◽  
H Goyeau ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycaemic Control ◽  
Insulin Glargine

Association between glycaemic control and fracture risk in diabetic patients: a nested case control study

2019 ◽  
Author(s):  
J Vavanikunnel ◽  
S Charlier ◽  
C Becker ◽  
C Schneider ◽  
SS Jick ◽  
...  
Keyword(s):  
Glycaemic Control ◽  
Fracture Risk ◽  
Case Control Study ◽  
Case Control ◽  
Diabetic Patients ◽  
Nested Case Control ◽  
Control Study

Clinical Experience with Insulin Detemir: Results from the Bangladesh Cohort of Global A1chieve Study

2013 ◽  
Vol 3 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Zafar Ahmed Latif ◽  
Md. Faruque Pathan ◽  
Md. Nazrul Islam Siddiqui ◽  
MA Mannan ◽  
SM Ashrafuzzaman ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Weight ◽  
Glycaemic Control ◽  
Insulin Therapy ◽  
Hba1c Level ◽  
Insulin Detemir ◽  
Entire Cohort ◽  
Baseline Visit ◽  
Effective Option

Objective: To present results from the Bangladesh cohort of the A1chieve study receiving insulin detemir (Levemir) ± oral anti diabetic drugs. Methods: Out of 1093 patients recruited from 49 sites in Bangladesh, 370 were initiated on insulin detemir (Levemir).Study visits were defined as baseline, interim (around 12 weeks from baseline) and final (around 24 weeks from baseline) visit. Results: Glycaemic control was poor in all the groups at baseline. In the entire cohort at 24 weeks, significant reductions from baseline were observed in mean HbA1c (from 10.0 % to 7.2%, p<0.001), FPG (from 10.5 to 6.7 mmol/L, p<0.001) and PPPG (from 15.3 to 8.9 mmol/L, p<0.001) levels. Overall 45.5% of the participants achieved target HbA1c level of < 7% after 24 weeks. The rate of all hypoglycaemic events in the entire cohort reduced from 1.34 (baseline) to 0.12 events/person year after 24 weeks of insulin detemir therapy (p<0.0001). There was no clinically relevant change in body weight in insulin naïve or prior insulin users groups after 24 weeks of insulin detemir therapy. Conclusions: The current study suggests that insulin detemir may be considered as a safe and effective option for initiating insulin therapy for type 2 diabetes in Bangladesh. Birdem Med J 2013; 3(1): 11-18 DOI: http://dx.doi.org/10.3329/birdem.v3i1.17121

The effects of CSII on glycaemic control, hypoglycaemia, DKA and BMI in paediatric T1D patients.

2015 ◽  
Author(s):  
Peter Aldiss ◽  
Priyha Santhanam ◽  
Kiran Kumar ◽  
Marianne Wolverson ◽  
Tabitha Randell ◽  
...  
Keyword(s):  
Glycaemic Control

Parental language proficiency and glycaemic control in children with type 1 diabetes

2018 ◽  
Author(s):  
Charlotte Jackson ◽  
Fiona Rutherford ◽  
Megan Shakesheff ◽  
Fiona Pinchin ◽  
Murray Bain ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Language Proficiency

797-P: Impact of Carbohydrate Counting on Glycaemic Control in People with Type 1 and Type 2 Diabetes on Intensified Insulin Therapy

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 797-P
Author(s):  
NORBERT HERMANNS ◽  
DOMINIC EHRMANN ◽  
BERNHARD KULZER
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Insulin Therapy ◽  
Carbohydrate Counting ◽  
Intensified Insulin Therapy
Sign in / Sign up

Export Citation Format

Share Document